2000生殖与避孕:英文版Requires access

Effects of Mifepristone Compound on the Receptors of Estrogen and Progesterone in Early Pregnancy Deciduas

金力, 沈维雄, 孙志达, 范光升, 乌毓明, 王寒正

Open publisher page 0 citations

Abstract

Objectives To examine the effect of mifepristone compound (mifepristone + anordrin) on estrogen receptor (ER) and progesterone receptor (PR) in early pregnancy decidua.Materials & Methods A Controlled study was carried out among 60 normal early pregnant volunteers ( ≤ 49 d) in the department of obstetric and gynecology of Peking Union Medical Hospital. The concentrations of ER and PR were measured by radioligand and were compared with the control subjects after oral administration of mifepristone or mifepristone compound in different doses.Results The concentration of PR decreased while that of ER increased significantly in the decidua from all subjects administrated with mifepristone compound. We also found the concentration of EcR in Group 5 (mifepristone 30 mg + AF- 53 5 mg) was the highest among 6 groups. The compound may be in favor of estrogen's action on endometrium.Conclusion The results indicate that mi f epristone compound with AF-53 has a coordinated function and can change the proportion of PR and ER. Hence, it can facilitate abortion. The compound dose of mifepristone 30 mg q- AF- 53 5 mg is in favor of the endometrium recovering.

About this research paper

What this paper is about

Objectives To examine the effect of mifepristone compound (mifepristone + anordrin) on estrogen receptor (ER) and progesterone receptor (PR) in early pregnancy decidua.Materials & Methods A Controlled study was carried out among 60 normal early pregnant volunteers ( ≤ 49 d) in the department of obstetric and gynecology of Peking Union Medical Hospital. The concentrations of ER and PR were measured by radioligand and were compared with the control subjects after oral administration of mifepristone or mifepristone compound in different doses.Results The concentration of PR decreased while that of ER increased significantly in the decidua from all subjects administrated with mifepristone compound. We also found the concentration of EcR in Group 5 (mifepristone 30 mg + AF- 53 5 mg) was the highest among 6 groups. The compound may be in favor of estrogen's action on endometrium.Conclusion The results indicate that mi f epristone compound with AF-53 has a coordinated function and can change the proportion of PR and ER. Hence, it can facilitate abortion. The compound dose of mifepristone 30 mg q- AF- 53 5 mg is in favor of the endometrium recovering.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objectives To examine the effect of mifepristone compound (mifepristone + anordrin) on estrogen receptor (ER) and progesterone receptor (PR) in early pregnancy decidua.Materials & Methods A Controlled study was carried out among 60 normal early pregnant volunteers ( ≤ 49 d) in the department of obstetric and gynecology of Peking Union Medical Hospital. The concentrations of ER and PR were measured by radioligand and were compared with the control subjects after oral administration of mifepristone or mifepristone compound in different doses.Results The concentration of PR decreased while that of ER increased significantly in the decidua from all subjects administrated with mifepristone compound. We also found the concentration of EcR in Group 5 (mifepristone 30 mg + AF- 53 5 mg) was the highest among 6 groups. The compound may be in favor of estrogen's action on endometrium.Conclusion The results indicate that mi f epristone compound with AF-53 has a coordinated function and can change the proportion of PR and ER. Hence, it can facilitate abortion. The compound dose of mifepristone 30 mg q- AF- 53 5 mg is in favor of the endometrium recovering.

Key concepts: Mifepristone, Decidua, Medical abortion, Abortifacient, Medicine, Progesterone receptor, Internal medicine, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of Mifepristone Compound on the Receptors of Estrogen and Progesterone in Early Pregnancy Deciduas — Research Paper | ScholarLens